Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. (Q44780590)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. |
scientific article published in March 2004 |
Statements
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy (English)
Paul K S Chan
Wing M Ho
Kwok C Lam
Kenny I K Lei
Anthony T C Chan
Jam J Lee
Thomas W T Leung
Sheng Zhong
Philip J Johnson